Remove 2015 Remove Competition Remove Networking
article thumbnail

Tips on Social Networking in the medical and healthcare industry

MedCepts

Tips and Benefits of Social Networking. Social networking is powerful when you understand the benefits (and recognize potential negatives) to investing your time and efforts across social sites. We have put together the top 5 tips and benefits of social networking for those in the medical and healthcare industry.

article thumbnail

Collaborations between pharma and academia increase

European Pharmaceutical Review

According to the survey, apprentice numbers are three times higher than 2015 statistics, across all skill levels from those entering the industry to master-qualified individuals. There are also intangible benefits, like demystifying each other’s sectors, and building networks with diverse teams from different scientific backgrounds.”.

Pharma 104
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Understanding the evidence used in drug product withdrawals

European Pharmaceutical Review

Observational studies should not be seen as competition to RCTs but as complementary to them, and as a sector we need to stop working in silos and develop an integrated and more comprehensive approach to evidence-based decision-making in safeguarding public health. Guide on Methodological Standards in Pharmacoepidemiology (Revision 11).

Medicine 116
article thumbnail

India’s telecom transformation: Innovation, investment and intellectual property

Clarivate

On June 25, 2024, Aayush Bhatnagar, Senior Vice President at Jio Platforms Limited, discussed the report during his panel discussion at the prestigious Ignite 2024 IP conference hosted by Clarivate — ‘I dentify your competitive advantage through IP & R&D benchmarking.’

article thumbnail

Indication Expansion: Pioneering new uses for existing cancer drugs

Clarivate

Our AI-based solutions systematically screen an asset’s Mechanism of Action (MoA) against numerous indications, using an updated collection of disease signatures and biological networks, ensuring a thorough and objective exploration of potential indications, that avoids subjective biases that may favor front-of-mind indications.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

article thumbnail

Clarify Health Launches No-Code Query Engine for Faster Access to Price Transparency Intelligence

Clarify Health

Users can also compare sourced rates across services, providers, and payers in any given market to quickly receive insight on their competitive negotiated rate standing against their peers. “Well organized price transparency data creates a new and essential category of business intelligence across the industry.